Karyopharm reports strong third quarter 2021 financial results and provides business highlights

Newton, mass., nov. 3, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the quarter ended september 30, 2021 and provided business highlights.

KPTI Ratings Summary

KPTI Quant Ranking